Company Directory > MedTech > Robert Bosch GmbH
Robert Bosch GmbH is a leading global supplier of technology and services, operating across four business sectors: Mobility, Industrial Technology, Consumer Goods, and Energy and Building Technology. While primarily known for automotive engineering, the company has significantly expanded into the healthcare sector through its subsidiary, Bosch Healthcare Solutions (BHCS), established in 2015. BHCS focuses on medical technology, molecular diagnostics, and digital health, leveraging the parent company's core competencies in sensor technology, micro-electromechanical systems (MEMS), and artificial intelligence. The company's healthcare portfolio is centered around the Vivalytic molecular diagnostics platform, which provides rapid point-of-care testing for infectious diseases, and the Vivatmo system for asthma management. Bosch also provides specialized services for the pharmaceutical industry, including AI-driven clinical trial data management, smart drug manufacturing solutions, and IoT-enabled medical device maintenance. As a privately held entity owned largely by a charitable foundation, Bosch reinvests a significant portion of its revenue into research and development, focusing on 'Invented for Life' technologies that bridge the gap between engineering and medical science.
CLASSIFICATION
Company Type:MedTech
Industry:Medical Devices
Sub-Industry:Diagnostics and Digital Health
SIZE & FINANCIALS
Employees:10000+
Revenue:$90B-$100B
Founded:1886
Ownership:private
Status:operating
FUNDING
Investors:Robert Bosch Stiftung (94% owner), Bosch Family (approx. 6% owner)
PIPELINE
Stage:Commercial
Lead Drug Stage:Not applicable (Medical Device focus)
Modalities:Molecular Diagnostics (PCR), Microfluidics, MEMS Sensors, AI/ML Algorithms, BioMEMS
Active Trials:2
Trial Phases:Phase 4: 2
FDA Approvals:1
EMA Approvals:5
CORPORATE STRUCTURE
Subsidiaries:Bosch Healthcare Solutions GmbH, Bosch Global Software Technologies, Bosch Sensortec GmbH, Grow Platform GmbH
Key Partnerships:Randox Laboratories (Strategic partnership for Vivalytic test development), R-Biopharm (Development of automated tests for multidrug-resistant bacteria), Methapharm Respiratory (US distribution of Vivatmo pro), BioGX (Molecular diagnostic test expansion), Robert Bosch Hospital (Clinical validation partner)
COMPETITION
Position:Niche Player
Competitors:Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Danaher (Cepheid), Becton, Dickinson and Company (BD)
LEADERSHIP
Key Executives:
Stefan Hartung - CEO, Robert Bosch GmbH
Marc Meier - General Manager, Bosch Healthcare Solutions
Board Members:Stefan Hartung, Christian Fischer, Markus Forschner, Tanja Rückert
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Robert Bosch GmbH. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.